Arkolith/Insider Trading/SBFM/Form 4/A

Slilaty Steve N.

Chief Executive Officer, Director, 10% OwnerSunshine Biopharma, Inc (SBFM) · full profile →Form 4/A · filed Oct 5, 2012
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2012Other(J)2.6M$0.05$130K31.5M
Dec 21, 2011Conversion(C)17.0M—$034.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 21, 2011Conversion(C)17.0M—$00

Transaction Codes

J
Other acquisition / disposition
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001013596-12-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for Sunshine Biopharma, Inc

Build

Ask your agent about SBFM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001013596-12-000009"
Ask your agent
Use Arkolith to summarize insider buying and selling at Sunshine Biopharma, Inc
over the last 90 days and cite the filings.